Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Janus Henderson Group
London,
| $2.72B | +$101M | 16 | 1.45% | Increased |
|
| 27 |
Jennison Associates
New York
| $2.29B | +$248M | 14 | 2.11% | Increased |
|
| 28 |
UBS Group
Zurich,
Switzerland
| $2.28B | +$194M | 81 | 0.9% | Increased |
|
| 29 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2.23B | -$128M | 70 | 1.13% | Reduced |
|
| 30 |
Ameriprise
Minneapolis,
Minnesota
| $2.22B | -$2.95M | 33 | 0.78% | Reduced |
|
| 31 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $2.15B | +$44.5M | 8 | 4.2% | Increased |
|
| 32 |
Dimensional Fund Advisors
Austin,
Texas
| $2.12B | +$1.58M | 37 | 0.81% | Increased |
|
| 33 |
Pictet Asset Management (UK)
London,
United Kingdom
| $2.05B | -$1.14M | 17 | 4.33% | Reduced |
|
| 34 |
ClearBridge Investments
New York
| $1.79B | -$21.6M | 15 | 1.54% | Reduced |
|
| 35 |
UBS AM
Chicago,
Illinois
| $1.64B | +$200M | 35 | 1.22% | Increased |
|
| 36 |
Charles Schwab
San Francisco,
California
| $1.63B | +$38.5M | 51 | 1.08% | Increased |
|
| 37 |
Edgewood Management
Greenwich,
Connecticut
| $1.61B | -$177M | 1 | 5.39% | Reduced |
|
| 38 |
TIAA CREF Investment Management
New York
| $1.56B | -$35.1M | 50 | 1.02% | Reduced |
|
| 39 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1.51B | +$81.3M | 77 | 0.63% | Increased |
|
| 40 |
American Century Companies
Kansas City,
Missouri
| $1.5B | +$65M | 17 | 1.46% | Increased |
|
| 41 |
AQR Capital Management
Greenwich,
Connecticut
| $1.5B | +$284M | 33 | 1.43% | Increased |
|
| 42 |
Legal & General Group
London,
United Kingdom
| $1.46B | +$48.6M | 54 | 1.05% | Increased |
|
| 43 |
Brown Advisory
Baltimore,
Maryland
| $1.41B | +$73.9M | 15 | 4.01% | Increased |
|
| 44 |
D.E. Shaw & Co
New York
| $1.35B | -$177M | 41 | 1.63% | Reduced |
|
| 45 |
OppenheimerFunds
New York
| $1.35B | +$48.3M | 19 | 1.57% | Increased |
|
| 46 |
Fred Alger Management
New York
| $1.33B | +$289M | 17 | 5% | Increased |
|
| 47 |
Harris Associates
Chicago,
Illinois
| $1.28B | +$9.5M | 1 | 2.01% | Increased |
|
| 48 |
AllianceBernstein
Nashville,
Tennessee
| $1.28B | +$142M | 50 | 0.83% | Increased |
|
| 49 |
Select Equity Group
New York
| $1.27B | -$26.8M | 5 | 9.4% | Reduced |
|
| 50 |
Renaissance Technologies
New York
| $1.27B | -$201M | 44 | 1.3% | Reduced |
|